CONSHOHOCKEN, PA — Cencora Inc. (NYSE: COR) will report results for its third quarter of fiscal 2026 before the opening bell on Aug. 5, providing investors with an update on the performance of one of the world’s largest pharmaceutical distribution and healthcare services companies.
The company announced it will release quarterly earnings before trading begins on the New York Stock Exchange, followed by a conference call at 8:30 a.m. Eastern Time to discuss the results.
President and Chief Executive Officer Robert P. Mauch and Executive Vice President and Chief Financial Officer Eva C. Boratto will host the call.
Investors and analysts can listen to the live webcast through Cencora’s investor relations website at investor.cencora.com. Participants accessing the webcast are encouraged to log in about 10 minutes before the scheduled start time.
The conference call can also be accessed by telephone at +1 (833) 461-5787 from the United States and Canada or +1 (585) 542-9983 internationally using meeting ID 632 369 927.
A replay of the webcast will be available on the company’s investor relations website approximately one hour after the call concludes and will remain accessible for one year.
Additional information and any updates regarding the webcast schedule are available at investor.cencora.com.
Cencora is a global pharmaceutical solutions company that provides pharmaceutical distribution, healthcare products and related services to manufacturers, providers and pharmacies. The company ranks No. 10 on the Fortune 500 and No. 17 on the Global Fortune 500, generating more than $300 billion in annual revenue.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.